Scarica l'app Stockscreener
5.20
2.16%
0.11
Dopo l'orario di chiusura:
5.18
-0.02
-0.38%
Precedente Chiudi:
$5.09
Aprire:
$5
Volume 24 ore:
31,040
Relative Volume:
0.65
Capitalizzazione di mercato:
$23.25M
Reddito:
$86.55M
Utile/perdita netta:
$-56.70M
Rapporto P/E:
-2.0223
EPS:
-2.5713
Flusso di cassa netto:
$4.87M
1 W Prestazione:
+2.56%
1M Prestazione:
-12.01%
6M Prestazione:
+13.22%
1 anno Prestazione:
-11.59%
Intervallo 1D:
$5.00
$5.2699
Intervallo di 1 settimana:
$4.56
$5.30
Portata 52W:
$2.813
$9.458
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
5.20 | 23.25M | 86.55M | -56.70M | 4.87M | -2.5713 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Iniziato | Northland Capital | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Downgrade | Janney | Buy → Neutral |
| 2018-01-24 | Reiterato | Janney | Buy |
| 2018-01-23 | Reiterato | The Benchmark Company | Buy |
| 2016-11-17 | Iniziato | Singular Research | Buy |
| 2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN
Harvard Bioscience CFO Frost buys $25,000 in HBIO stock - Investing.com
Harvard Bioscience (NASDAQ: HBIO) CFO awarded 30,000 RSUs in equity grant - Stock Titan
Harvard Bioscience (HBIO) CFO adds 5,000 shares at $5.00 - Stock Titan
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Is Harvard Bioscience Inc stock a top performer YTD2026 Growth vs Value & Reliable Entry Point Alerts - baoquankhu1.vn
Debt to assets ratio of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
Trading Recap: Is Harvard Bioscience Inc forming a bullish divergenceWeekly Investment Summary & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
EBIT of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
HARVARD BIOSCIENCE (NASDAQ: HBIO) CEO receives 75,000-share stock grant - Stock Titan
William Snider Secures Board Seat at Harvard Bioscience with 15.97% Stake - TradingView
BroadOak reports 16% Harvard Bioscience (HBIO) stake tied to loans and warrants - Stock Titan
Harvard Bioscience stock faces scrutiny amid Q4 earnings anticipation and life sciences sector volat - AD HOC NEWS
Taxes of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience Outlines Post-Refi Strategy, Organoid Growth Focus - National Today
Total equity of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LS:A423J5 - TradingView
Free cash flow per share of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Cash per share of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Harvard Bioscience, Inc. Cash Flow – GETTEX:HBI0 - TradingView
Net income of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Price to earnings ratio of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Net debt of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Return on assets % of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Total revenue of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LSX:A423J5 - TradingView
Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - GuruFocus
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares - MarketBeat
Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan
Harvard Bioscience director Snider buys $103,603 in HBIO stock By Investing.com - Investing.com Australia
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares - MarketBeat
Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com
Harvard Bioscience (HBIO) director buys 21,000 shares on open market - Stock Titan
Harvard Bioscience CEO Duke buys $25k in shares By Investing.com - Investing.com Australia
Layoff Watch: What are analysts price targets for Harvard Bioscience IncTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Insider Buying: John Duke Acquires 5,000 Shares of Harvard Biosc - GuruFocus
Harvard Bioscience CEO Duke buys $25k in shares - Investing.com
Harvard Bioscience (HBIO) CEO adds shares and holds major RSU awards - Stock Titan
Harvard Bioscience at KeyBanc Forum: Strategic Growth and Market Focus By Investing.com - Investing.com Canada
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - minichart.com.sg
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning - TipRanks
Market Trends: Whats next for Harvard Bioscience Inc stockRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Harvard Bioscience provides investor presentation; FY25 results, FY26 guidance and strategic actions - TradingView
Harvard Bioscience (NASDAQ: HBIO) posts FY25 metrics and guides modest 2026 growth - Stock Titan
HBIO: Benchmark Raises Price Target to $6.00, Maintains Speculat - GuruFocus
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split - Investing.com Australia
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):